Recruiting A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation NCT07458347 Conditions Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +44 more Locations Cedars-Sinai Medical Center — Los Angeles, California, United States Florida Cancer Specialists — Sarasota, Florida, United States Moffitt Cancer Center — Tampa, Florida, United States Mass General Brigham Cancer Institute at Massachusetts General Hospital — Boston, Massachusetts, United States View more locations Show fewer locations Loading locations... View Trial Details
